Prostate cancer hormone treatment and osteoporosis
Hormone therapy to block testosterone is one of a range of treatments used for prostate cancer. It may be used alongside radiotherapy to help make that treatment more effective, and to reduce the chance of cancer cells returning in the longer term.
However, some men experience thinning of the bones or osteoporosis as a side effect of long-term hormone therapy.
Not all men will develop osteoporosis in this way. If the consultant is concerned before treatment begins, they may arrange a bone mineral density assessment called a DEXA scan.
This special type of X- is a safe and non-invasive way to diagnose osteoporosis, detect low bone density, monitor the effectiveness of treatments, and predict the risk of future fractures.
Reducing osteoporosis risk
To help reduce the risk of osteoporosis from prostate cancer hormone treatment, doctors may recommend: